English | Español
Press release submission | Jul 3, 2022

Innovent Announces First Patient Dosed in a Phase 2 Clinical study of IBI112 (IL-23p19 Monoclonal Antibody) in Patients with Moderate-to-Severe Active Ulcerative Colitis
Press release submission | Jul 1, 2022

More Surgical Care Cuts Take Effect Today, Harming Patients
Press release submission | Jul 1, 2022

FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir

Press release submission | Jun 30, 2022

Big Win for Patients: Aetna Drops Prior Authorization for Most Cataract Surgeries

Press release submission | Jun 29, 2022

New Study: Oxaloacetate Reduces Chronic Fatigue In Just Six Weeks, Promising Data for ME/CFS Patients

Press release submission | Jun 24, 2022

BioFluidica Next-Generation Liquid Biopsy Platform Uncovers Undiagnosed HER2+ Patients

Press release submission | Jun 24, 2022

OM1 Launches a New Estimation Model for the Expanded Disability Status Score (EDSS) for Multiple Sclerosis Patients

Press release submission | Jun 23, 2022

CHMP issues a positive opinion recommending full approval of Oncopeptides Pepaxti in EU for patients with triple class refractory multiple myeloma

Trending
Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors
+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’
+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’
+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’